Opti-Derm can be maintained by cryopreservation technology and stably produced in different sizes and forms for the various needs of the patient.
Obtained from the transgenic miniature pig, the Opti-Cornea has excellent biocompatibility and can be utilized for customized transplantation depending on the needs of the patient. At present, non-clinical trials on primate monkeys using a full thickness corneal transplant are underway and the implanted cornea has been successful and stable for over 6 months.
The Opti-Islet can be used as a radical treatment for type 1 diabetes patients with little to no insulin secretion. Optipharm has successfully established an isolation technique of the islet and its cultivation through transgenic miniature pigs, and have seen outstanding results of islet function in rodent experiments. Transplant islet experimentation with non-human primate models to measure islet functionality and success rate will soon be underway.
Korean